CS MEDICA intensifies its presence on Amazon platforms
CS MEDICA A/S (”CS MEDICA” or the ”Company”) sells their Cannasen® CBD product line on Amazon Germany and Amazon Sweden, but is not experiencing the uplift in sales as expected. Henceforward CS Medica is intensifying their presence on Amazon platforms and has entered a cooperation with Incubeta, an Amazon service provider specialized within CBD products.
CS MEDICA is selling its Cannasen® CBD brand on Amazon Germany and Amazon Sweden but is not experiencing the sales uplift as expected. Hence, the roll-out to France, Italy, and other countries has been on hold.
To intensify the company’s presence on Amazon, CS MEDICA has decided not to extend their existing contract with their current Amazon service provider Ampilio.
Heidi Ahlefeldt-Laurvig, CMO & CGO comments:
“Ampilio has done a great job helping us launch on both the Swedish and German Amazon; however, we experience products containing CBD need a different strategy and communication. The speed to market has been too slow; consequently, we agreed to move our partnership to Incubeta Maze-One, a preferred Amazon partner like Ampilio, but who is familiar working with CBD brands on Amazon.”
Ulrik Grevenkop-Castenskiold, Managing Director, Incubeta Maze-One Nordic continues:
“We work with several Nordic brands within personal care, including CBD-based products, where we see an increasing sales potential in Europe. Selling CBD-based products on Amazon comes with certain compliance demands that require special solutions and communication tactics. We look forward to working with CS MEDICA to build and grow Amazon as a sales channel.”
A revised strategy and an intensive launch plan are being executed in September/October. The aim is to grow awareness of the Cannasen® CBD brand and capture market shares across Europe, especially in the larger Amazon markets such as Germany, the UK, France, and Italy. For Spain, a roll-out will be either with Incubeta Maze-One or a preferred distributor.
For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.
The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.